AngioDynamics kept at outperform by RBC

RBC Capital Markets analyst Phil Nalbone kept AngioDynamics Inc. at an outperform rating, speculative risk, and a $30 price target. The company hired Robert D. Mitchell to fill its newly created position of executive vice president and chief operating officer, reporting directly to president and chief executive officer Eamonn Hobbs. Hobbs is expected to spend more time on AngioDynamics' growth initiatives, including possible acquisitions using the nearly $90 million in cash on the company's balance sheet, according to the analyst. Shares of the Queensbury, N.Y.-based medical device company were up 94 cents, or 4.08%, at $23.96. (Nasdaq: ANGO)

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.